Pyxis Oncology (PYXS) Treasury Shares (2020 - 2025)

Pyxis Oncology (PYXS) has 6 years of Treasury Shares data on file, last reported at $1.6 million in Q4 2025.

• Treasury Shares for Q4 2025 came in at $1.6 million, down 35.49% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.6 million (down 35.49% YoY), and the FY2025 annual result was $1.6 million, down 35.49% from the prior year.
• Treasury Shares retreated to $1.6 million in Q4 2025 per PYXS's latest filing, from $1.8 million in the prior quarter.
• Over five years, Treasury Shares peaked at $5.7 million in Q1 2023 and troughed at $554724.0 in Q3 2021.
• A 5-year average of $2.7 million and a median of $3.0 million in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2024: Treasury Shares jumped 463.22% in 2022, then sank 45.88% in 2024.
• A 5-year view of Treasury Shares shows it stood at $618494.0 in 2021, then surged by 387.54% to $3.0 million in 2022, then gained by 20.43% to $3.6 million in 2023, then plunged by 30.23% to $2.5 million in 2024, then plunged by 35.49% to $1.6 million in 2025.
• Business Quant data shows PYXS's Treasury Shares at $1.6 million in Q4 2025, $1.8 million in Q3 2025, and $1.9 million in Q2 2025.